Search Results 891-900 of 108870 for b-
Martin-Castillo B, Verdura S, Llop-Hernandez A, Lupu R, Cuyas E, Menendez JA. Metabolic hallmarks of trastuzumab resistance. Expert Opin Ther Targets.
Types · MEN 2A . This also is known as classical MEN 2A or Sipple syndrome. It causes medullary thyroid cancer and noncancerous tumors of the parathyroid glands ...
Kristen B. McCullough, Pharm.D., R.Ph. Rochester, MN. Area of Focus: Acute lymphocytic leukemia, Acute myelogenous leukemia, Myelodysplastic syndromes, ...
This microscopic organism is a parasite that can live in your digestive system. Whether it causes digestive problems isn't clear.
A Phase 2, Multicenter, Randomized, Open-label Study of MEDI-551 in Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) · Overview.
Kharfan Dabaja, M.D.. Jacksonville, FL. Area of Focus: Bone marrow transplant, CAR-T cell therapy, Chronic lymphocytic leukemia, B-cell lymphoma, Diffuse large ...
The RNA Nanotherapeutics Lab of Tushar C. Patel, M.B., Ch.B., at Mayo Clinic hopes to develop RNA-based therapies and biological nanoparticles to treat ...
A Study of Itacitinib (INCB039110) in Combination With Ibrutinib in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma · Overview · Participation ...
Pourzand P, Metzger A, Moore J, Salverda B, Hai H, Suresh M, Bubier S, Bachista K, Segond N, Debaty G, Lurie K. Survival with one versus three centimeters ...
Displaying 21-6 out of 6 doctors available. Last Name Initial: B ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.